PA007531.r1: Recombinant Anti-mouse VEGFR-2 Monoclonal Antibody (Clone: DC101), Rat IgG1 Kappa
Recombinant Rat IgG1 Monoclonal Antibody.
Conjugation: non-conjugated.
Specificity/Sensitivity: The recombinant VEGFR-2 monoclonal antibody (clone: DC101) specifically binds to the mouse VEGFR-2.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).
PA007531.h1Fs: Recombinant Anti-mouse VEGFR-2 Monoclonal Antibody (Clone: DC101), Human IgG1 Fc Silent Kappa
Recombinant Human IgG1 Monoclonal Antibody.
Conjugation: non-conjugated.
Specificity/Sensitivity: The recombinant VEGFR-2 monoclonal antibody (clone: DC101) specifically binds to the mouse VEGFR-2.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).
PA007777.h1Fs-b: Biotinylated Recombinant Anti-mouse VEGFR-2 Monoclonal Antibody (Clone: DC101), Human IgG1 Fc Silent Kappa
Recombinant human IgG1 Monoclonal Antibody with site-directed biotinylation through the Avi tag at the C-terminus of the antibody heavy chain.
Conjugation: Biotin-conjugated.
Specificity/Sensitivity: The site-directed biotinylated recombinant DC101 antibody specifically binds to mouse VEGFR-2.
Applications: Flow cytometry (FC) with various dye conjugation through streptavidin; conjugation to streptavidin agarose beads or streptavidin magnetic beads.
BP001796-CE91: Recombinant Human DNA Fragmentation Factor Subunit Alpha (DFFA) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001796-PRO-718: Recombinant Human DNA Fragmentation Factor Subunit Alpha (DFFA) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.C003: Humira Biosimilar Stable Cell Line (CHO)
The yield of Humira biosimilar from the CHO stable cell line was above 2.0 g/L in a 50 liter manufacturing.
C011P: Infliximab Biosimilar, TNF alpha Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody Infliximab biosimilar specifically binds to the human TNF alpha.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Infliximab.C011: Remicade Biosimilar Stable Cell Line (CHO)
The yield of Remicade biosimilar from the CHO stable cell line was above 1.5 g/L in flask.